|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.576
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.289
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.170
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.102
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.091
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.090
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.089
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.087
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.081
|
|
|
|
protein palmitoylation
|
GO:0018345 |
14 |
0.080
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.076
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.076
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.074
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.069
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.065
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.064
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.059
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.058
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.054
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.054
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.052
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.048
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.047
|
|
|
|
sphingosine metabolic process
|
GO:0006670 |
4 |
0.047
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.045
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.045
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.044
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.043
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.043
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.042
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.042
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.041
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.039
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.038
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.038
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.038
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.037
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.037
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.037
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.036
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.036
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.036
|
|
|
|
golgi to endosome transport
|
GO:0006895 |
3 |
0.034
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.033
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.032
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.032
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.032
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.032
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.031
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.030
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.030
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.029
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.029
|
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
1 |
0.029
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.028
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.028
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.028
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.027
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.027
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.027
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.026
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.026
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.026
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.025
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.025
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.025
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.025
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.025
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.025
|
|
|
|
regulation of synapse assembly
|
GO:0051963 |
29 |
0.025
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.024
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.024
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.024
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.023
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.023
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.023
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.023
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.023
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.023
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.022
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.022
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.022
|
|
|
|
intra golgi vesicle mediated transport
|
GO:0006891 |
1 |
0.022
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.022
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.022
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.022
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.022
|
|
|
|
rhodopsin mediated signaling pathway
|
GO:0016056 |
4 |
0.021
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.021
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.021
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.021
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.021
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.021
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.021
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.021
|
|
|
|
hydrogen ion transmembrane transport
|
GO:1902600 |
25 |
0.021
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.021
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.020
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.020
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.020
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.020
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.020
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.020
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.020
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.019
|
|
|
|
lipoprotein biosynthetic process
|
GO:0042158 |
33 |
0.019
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.019
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.019
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.019
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.019
|
|
|
|
protein localization to endosome
|
GO:0036010 |
2 |
0.019
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.019
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.019
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.019
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.019
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.019
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.019
|
|
|
|
regulation of transposition
|
GO:0010528 |
2 |
0.018
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.018
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.018
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.018
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.018
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.018
|
|
|
|
glycosylceramide metabolic process
|
GO:0006677 |
4 |
0.018
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.018
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.018
|
|
|
|
hexose catabolic process
|
GO:0019320 |
3 |
0.017
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.017
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.017
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.017
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.017
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.017
|
|
|
|
positive regulation of mitochondrial calcium ion concentration
|
GO:0051561 |
3 |
0.017
|
|
|
|
sphingoid metabolic process
|
GO:0046519 |
5 |
0.017
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.017
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.016
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.016
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.016
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.016
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.016
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.016
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.016
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.016
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.016
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.015
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.015
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.015
|
|
|
|
nuclear membrane organization
|
GO:0071763 |
4 |
0.015
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.015
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.015
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.015
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.015
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.015
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.015
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.015
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.015
|
|
|
|
cellular pigmentation
|
GO:0033059 |
20 |
0.015
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.015
|
|
|
|
l ascorbic acid metabolic process
|
GO:0019852 |
4 |
0.015
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.015
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.014
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.014
|
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
33 |
0.014
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.014
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.014
|
|
|
|
protein lipidation
|
GO:0006497 |
28 |
0.014
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.014
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.014
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.014
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.014
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.014
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.014
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.014
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.014
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.013
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.013
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.013
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.013
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.013
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.013
|
|
|
|
regulation of clathrin mediated endocytosis
|
GO:2000369 |
4 |
0.013
|
|
|
|
calcium mediated signaling using intracellular calcium source
|
GO:0035584 |
3 |
0.013
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.013
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.013
|
|
|
|
regulation of lamellipodium assembly
|
GO:0010591 |
3 |
0.013
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.013
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.013
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.012
|
|
|
|
cell cycle switching
|
GO:0060184 |
1 |
0.012
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.012
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.012
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.012
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.012
|
|
|
|
ketone catabolic process
|
GO:0042182 |
3 |
0.012
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.012
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.012
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.012
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.012
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.012
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.012
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.012
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.012
|
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
23 |
0.012
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.012
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
29 |
0.012
|
|
|
|
positive regulation of exocytosis
|
GO:0045921 |
20 |
0.012
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.012
|
|
|
|
uronic acid metabolic process
|
GO:0006063 |
2 |
0.012
|
|
|
|
retrograde vesicle mediated transport golgi to er
|
GO:0006890 |
1 |
0.012
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.012
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.012
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.012
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.012
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.012
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.011
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.011
|
|
|
|
nuclear envelope organization
|
GO:0006998 |
11 |
0.011
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.011
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.011
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.011
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.011
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.011
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.011
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.011
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.011
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.011
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.011
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.011
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.011
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.011
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.011
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.011
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.011
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.011
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.011
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.011
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.011
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.011
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.011
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.011
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.011
|
|
|
|
modification by symbiont of host morphology or physiology
|
GO:0044003 |
4 |
0.011
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.011
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.010
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.010
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.010
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.010
|
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.010
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.010
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.010
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.010
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.010
|
|
|
|
localization within membrane
|
GO:0051668 |
4 |
0.010
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.010
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.010
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.010
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.010
|
|
|
|
chloride transmembrane transport
|
GO:1902476 |
24 |
0.010
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.010
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.010
|
|